The University of Michigan School of Medicine recently jumped on the no-pharma-funding bandwagon: It will stop accepting commercial support of CME on January 1, 2011. According to a statement by the dean of the medical school and associate dean of regulatory affairs, “The decision was based on a review of literature about the influence on clinical faculty of industry-funded CME.” The Sloan Kettering Memorial Cancer Center in New York and Kaiser Permanente’s mid-Atlantic region also have ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.